Hematologic Malignancy
Angiocentric Immunoproliferative Lesion
CI-CAN-00000451AILExplore in graph →
HematologicNon-malignant2 active trials
- NCIt
- C40970
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00000451AILExplore in graph →
Clinical trials
83 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01815749 | Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma | active not recruiting | Phase 1 | 30 | City of Hope Medical CenterOTHER | 1 | Jun 25, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Jun 25, 2026source: clinicaltrials